Cell Source, Inc. (CLCS) › Shareholders' EquityCell Source, Inc. (CLCS) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2012: -$147.4K2013: -$697.3K2014: -$3.78M2015: -$5.76M2016: -$6.24M2017: -$4.56M2018: -$4.92M2019: -$5.74M2020: -$7.95M2021: -$9.83M2022: -$12.63M2023: -$15.61M2024: -$18.54M-$18.54M2012Shareholders' Equity (USD)2024Fiscal YearShareholders' EquityChange YoY2024-$18.54M-18.7%2023-$15.61M-23.6%2022-$12.63M-28.6%2021-$9.83M-23.6%2020-$7.95M-38.4%2019-$5.74M-16.7%2018-$4.92M-8.0%2017-$4.56M+27.0%2016-$6.24M-8.4%2015-$5.76M-52.2%2014-$3.78M-442.6%2013-$697.3K-373.2%2012-$147.4K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share